e-learning
resources
Munich 2014
Sunday, 07.09.2014
Prevalence of COPD and mortality from COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Characteristics of patients newly prescribed a long acting bronchodilator in the United Kingdom (UK)
S. Landis, K. Wurst, H. Le, H. Muellerova, K. Davis (Uxbridge, United Kingdom; Research Triangle Park, United States Of America; Wavre, Belgium)
Source:
International Congress 2014 – Prevalence of COPD and mortality from COPD
Session:
Prevalence of COPD and mortality from COPD
Session type:
Thematic Poster Session
Number:
1074
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Landis, K. Wurst, H. Le, H. Muellerova, K. Davis (Uxbridge, United Kingdom; Research Triangle Park, United States Of America; Wavre, Belgium). Characteristics of patients newly prescribed a long acting bronchodilator in the United Kingdom (UK). Eur Respir J 2014; 44: Suppl. 58, 1074
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Characteristics of patients newly prescribed a long acting bronchodilator in the US
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013
Asthma ICs prescriptions in primary care in France and the United Kingdom: Are they similar?
Source: International Congress 2016 – Asthma management in primary care
Year: 2016
The DACCORD study: Real-life COPD outpatient treatment with long-acting bronchodilators in Germany
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013
Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Astro-Lab project: Assessment of the safety of long-acting beta agonists (LABAs) in asthma by combining health-care databases and direct patient follow-up: Description of the patient pattern in France and in the United-Kingdom (UK)
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013
LATE-BREAKING ABSTRACT: The use of benzodiazepines in COPD: A population-based study of Norway
Source: Annual Congress 2013 –Highlights in epidemiology of respiratory disease
Year: 2013
Long-acting anti-muscarinic agents (LAMA) frequency of use and clinical features of patients with severe asthma in real-life setting: data from the Severe Asthma Network in Italy (SANI) registry
Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Year: 2019
The effect of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A real practice analysis in Italy
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
Prescribing patterns for UK patients commencing first maintenance therapy for COPD
Source: International Congress 2014 – COPD markers
Year: 2014
Drug treatment in a German real-life COPD cohort (DACCORD)
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
A new user cohort study comparing the risk of pneumonia in inhaled corticosteroid (ICS) vs. long-acting bronchodilator (LABD) regimens in COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Economic outcomes in the United States of treating COPD with inhaled corticosteroids and long-acting β-agonists in a managed care setting
Source: Eur Respir J 2003; 22: Suppl. 45, 216s
Year: 2003
The clinical impact of long-acting bronchodilators in newly diagnosed COPD patients
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013
Changes in prescriped inhaled COPD medication during a 3 year period in Denmark. A registry study
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013
Use of long acting bronchodilators and inhaled corticosteroids within 30-days of discharge in older adults hospitalized for AECOPD
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
Statin use and risk of exacerbations in individuals with COPD: The Copenhagen general population study
Source: International Congress 2014 – New insights into the epidemiology of COPD
Year: 2014
Assessment of factors influencing adherence to asthma treatment among 12-17 year olds: A multi-national survey in France, Germany, Spain and United Kingdom
Source: International Congress 2016 – Asthma management in primary care
Year: 2016
Canadian physicians are concerned about the use of inhaled corticosteroids (ICS) in COPD management
Source: International Congress 2014 – Management of asthma and other respiratory diseases in primary care
Year: 2014
Hospital resource use for COPD patients varies by both clinical commissioning group and primary care practices across nine CCGs in the United Kingdom
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
Changes in the treatment of asthma in Spain in the last twenty years. A population based study (ECRHS)
Source: International Congress 2014 – Epidemiology of asthma
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept